SB INVESTMENT ADVISERS (UK) LTD
SEC CIK 1731509 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NRGV | Energy Vault Holdings, Inc. | 10% | 15.54M | — | $16.95M | 1 | 2026-01-15 | 2026-01-15 |
| VIR | Vir Biotechnology, Inc. | 10% | 14.66M | — | $86.78M | 22 | 2021-12-20 | 2025-10-24 |
| CPNG | Coupang, Inc. | 10% | 309.54M | — | $2.99B | 4 | 2022-03-09 | 2025-06-13 |
| COMP | Compass, Inc. | 10% | 58.07M | — | $182.77M | 3 | 2024-05-16 | 2024-12-17 |
Most active insiders at NRGV, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | SB INVESTMENT ADVISERS (UK) LTD | 10% | — | $16.95M |
| 2 | Beer Michael Thomas | CFO | — | $717.4K |
| 3 | Ladwa Akshay | Chief Ops Off | $12.4K | $456.8K |
| 4 | Unwin Stephanie | Dir | — | $427.0K |
| 5 | Hixon Dylan | Dir | $426.3K | — |
| 6 | Piconi Robert | CEO, Dir, 10% | $94.6K | — |
| 7 | Ertel Thomas R | Dir | $18.4K | — |
| 8 | Mandanas Mary Beth | Dir | $18.2K | — |
| 9 | Paulson Larry | Dir | $15.8K | — |
| 10 | Dahiya Nitin | CFO | — | — |
Transactions 30
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2026-01-20 | 2026-01-15 | NRGV | Energy Vault Holdings, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $5.65 | -3.00M | 15.54M | -16% | -$16.95M |
| MI | 2025-10-28 | 2025-10-24+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.01 | -113.1K | 14.66M | -0.8% | -$680.0K |
| MI | 2025-10-24 | 2025-10-22+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.07 | -298.6K | 14.87M | -2% | -$1.81M |
| MI | 2025-10-09 | 2025-10-07+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $5.99 | -538.4K | 16.09M | -3% | -$3.22M |
| I | 2025-06-17 | 2025-06-13 | CPNG | Coupang, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $28.25 | -10.00M | 309.54M | -3% | -$282.50M |
| I | 2025-05-12 | 2025-05-08 | CPNG | Coupang, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.75 | -30.00M | 319.54M | -9% | -$772.50M |
| I | 2024-12-19 | 2024-12-17 | COMP | Compass, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.33 | -10.00M | 58.07M | -15% | -$63.30M |
| I | 2024-09-17 | 2024-09-13 | COMP | Compass, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $6.24 | -7.50M | 68.07M | -10% | -$46.80M |
| I | 2024-05-20 | 2024-05-16 | COMP | Compass, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $4.30 | -16.90M | 75.57M | -18% | -$72.67M |
| MI | 2024-03-14 | 2024-03-12+ | CPNG | Coupang, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $19.20 | -46.61M | 365.07M | -11% | -$894.93M |
| MI | 2023-06-30 | 2023-06-28+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.17 | -97.0K | 16.77M | -0.6% | -$2.44M |
| MI | 2023-06-06 | 2023-06-02+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.32 | -39.6K | 17.14M | -0.2% | -$1.08M |
| MI | 2023-05-25 | 2023-05-23+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.46 | -274.5K | 17.28M | -2% | -$7.26M |
| I | 2023-05-09 | 2023-05-05 | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.10 | -136 | 17.64M | -0.0% | -$3,414 |
| MI | 2023-05-05 | 2023-05-03+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.53 | -198.0K | 17.64M | -1% | -$5.06M |
| MI | 2023-04-26 | 2023-04-24+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.42 | -67.0K | 17.84M | -0.4% | -$1.70M |
| MI | 2023-02-15 | 2023-02-13+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.28 | -118.0K | 18.43M | -0.6% | -$3.10M |
| MI | 2023-01-19 | 2023-01-17+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.28 | -190.8K | 19.60M | -1.0% | -$5.01M |
| MI | 2023-01-17 | 2023-01-12+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.58 | -211.7K | 19.79M | -1% | -$5.63M |
| MI | 2023-01-10 | 2023-01-06+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $26.03 | -101.0K | 20.18M | -0.5% | -$2.63M |
| MI | 2023-01-05 | 2023-01-03+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.57 | -9,177 | 20.25M | -0.0% | -$234.6K |
| MI | 2022-12-27 | 2022-12-22+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.93 | -175.2K | 20.46M | -0.8% | -$4.54M |
| MI | 2022-12-22 | 2022-12-20+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $25.84 | -215.8K | 20.60M | -1% | -$5.58M |
| I | 2022-11-23 | 2022-11-22 | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.27 | -65.2K | 21.18M | -0.3% | -$1.78M |
| MI | 2022-11-22 | 2022-11-18+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.21 | -26.0K | 21.24M | -0.1% | -$706.8K |
| MI | 2022-11-18 | 2022-11-16+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.42 | -210.0K | 21.34M | -1.0% | -$5.76M |
| MI | 2022-11-16 | 2022-11-14+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.61 | -138.0K | 21.57M | -0.6% | -$3.81M |
| MI | 2022-08-17 | 2022-08-15+ | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $27.97 | -130.4K | 22.09M | -0.6% | -$3.65M |
| I | 2022-03-11 | 2022-03-09 | CPNG | Coupang, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $20.87 | -50.00M | 461.16M | -10% | -$1.04B |
| I | 2021-12-22 | 2021-12-20 | VIR | Vir Biotechnology, Inc. | SB INVESTMENT ADVISERS (UK) LTD | 10% | S - Sale | $52.73 | -400.0K | 22.22M | -2% | -$21.09M |
Purchase Sale Sale after option exercise All abbreviations